J&J Stent Patent Suit Damages From Medtronic Include $77 Mil. In Royalties
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's $271.1 mil. damages award in its stent patent suit against rival Medtronic includes roughly $77 mil. in royalties.
You may also be interested in...
J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
J&J Expands Damages In Express2 Injunction Bid; BSC Adds Counterclaims
Claims made by Johnson & Johnson/Cordis' legal counsel arguing a patent infringement case against Boston Scientific/Scimed may be further buttressed by previous actions taken by a Delaware district court